The latest price target for Privia Health Gr (NASDAQ:PRVA) was reported by Barclays on November 8, 2024. The analyst firm set a price target for $21.00 expecting PRVA to fall to within 12 months (a possible -0.38% downside). 21 analyst firms have reported ratings in the last year.

The latest analyst rating for Privia Health Gr (NASDAQ:PRVA) was provided by Barclays, and Privia Health Gr maintained their equal-weight rating.

The last upgrade for Privia Health Group Inc happened on February 22, 2022 when Cowen & Co. raised their price target to $35. Cowen & Co. previously had a market perform for Privia Health Group Inc.

The last downgrade for Privia Health Group Inc happened on February 22, 2024 when B of A Securities changed their price target from $27 to $21 for Privia Health Group Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Privia Health Gr, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Privia Health Gr was filed on November 8, 2024 so you should expect the next rating to be made available sometime around November 8, 2025.

While ratings are subjective and will change, the latest Privia Health Gr (PRVA) rating was a maintained with a price target of $19.00 to $21.00. The current price Privia Health Gr (PRVA) is trading at is $21.08, which is out of the analyst’s predicted range.